Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Randomized Trials Underway For Renal Denervation To Treat Hypertension

This article was originally published in The Gray Sheet

Executive Summary

Ardian is moving forward with a prospective randomized clinical trial to study its Symplicity radiofrequency catheter for ablation of the sympathetic renal nerves to treat chronic hypertension, following successful results of its first-in-man study
Advertisement

Related Content

Ardian Targets 2011 For First Launch Of RF Catheter That Treats Hypertension
Ardian Targets 2011 For First Launch Of RF Catheter That Treats Hypertension

Topics

Advertisement
UsernamePublicRestriction

Register

MT028002

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel